Stemson Therapeutics procures $15m Series A

Stemson Therapeutics, a San Diego-based pre-clinical stage cell therapy company, has raised $15 million in Series A funding.

16 July 2021•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles